Although the expression pattern of TGF-β in the lesional skin of SSc is still controversial, TGF-β expression levels generally seem to be higher in patients with early and active disease, but weak or undetectable in patients with established skin fibrosis. Here, TGFB1 is linked to systemic sclerosis.